Application of transcriptomics in Chinese herbal medicine studies  by Lo, Hsin-Yi et al.
     Journal of Traditional and Complementary Medicine Vo1. 2, No. 2, pp. 105-114




Application of transcriptomics in Chinese herbal 
medicine studies
Hsin-Yi Lo1, Chia-Cheng Li1, Hui-Chi Huang2, Li-Jen Lin3, Chien-Yun Hsiang4, §, and  
Tin-Yun Ho1,*, §
§ Contributed equally
1 Graduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
2 School of Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 40402, Taiwan.
3 School of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
4 Department of Microbiology, China Medical University, Taichung 40402, Taiwan.
Abstract
Transcriptomics using DNA microarray has become a practical and popular tool for herbal medicine study because of 
high throughput, sensitivity, accuracy, specificity, and reproducibility. Therefore, this article focuses on the overview of 
DNA microarray technology and the application of DNA microarray in Chinese herbal medicine study. To understand 
the number and the objectives of articles utilizing DNA microarray for herbal medicine study, we surveyed 297 
frequently used Chinese medicinal herbs listed in Pharmacopoeia Commission of People’s Republic of China. We 
classified these medicinal herbs into 109 families and then applied PudMed search using "microarray" and individual 
herbal family as keywords. Although thousands of papers applying DNA microarray in Chinese herbal studies have 
been published since 1998, most of the articles focus on the elucidation of mechanisms of certain biological effects of 
herbs. Construction of the bioactivity database containing large-scaled gene expression profiles of quality control herbs 
can be applied in the future to analyze the biological events induced by herbs, predict the therapeutic potential of herbs, 
evaluate the safety of herbs, and identify the drug candidate of herbs. Moreover, the linkage of systems biology tools, 
such as functional genomics, transcriptomics, proteomics, metabolomics, pharmacogenomics and toxicogenomics, will 
become a new translational platform between Western medicine and Chinese herbal medicine.
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Introduction
Systems biology employing omics as research tools 
has been used for Chinese herbal medicine study. 
Omics, such as functional genomics, transcriptomics 
and proteomics, can be applied to study the gene/protein 
functions of medicinal herbs and to evaluate the 
herb/host interactions. Moreover, metabolomics, 
pharmacogenomics, and toxicogenomics can be utilized 
to examine the chemical processes involving metabolites 
of medicinal herbs, to investigate the variations within 
the host genome and herbs, and to analyze the toxic 
effects of herbs (Barlow et al., 2012; Buriani et al., 
2012; Hsiang et al., 2009; Kuete and Efferth, 2011; 
Pelkonen et al., 2012; Sertel et al., 2012; Youns et 
al., 2010). Transcriptomics using DNA microarray 
has become a practical and popular tool for herbal 
medicine study because of high throughput, sensitivity, 
accuracy, specificity, and reproducibility. Thousands 
of papers applying DNA microarray in Chinese herbal 
This is an open access article under the CC BY-NC-ND license.
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study have been published since 1998. Therefore, this 
article focuses on the overview of DNA microarray 
technology and the application of DNA microarray in 
Chinese herbal medicine study. Furthermore, the linkage 
of systems biology tools and its application as a new 
translational platform between Western medicine and 
Chinese herbal medicine are discussed.
An overview of DNA microarray technology
Microarray technology was created by Dr. Schena 
and his colleagues at Stanford University in 1995 
(Schena et al., 1995). They published the first paper on 
the use of cDNA microarray probes that were printed 
in a two-dimensional grid onto glass slides. In 1996, 
Affymetrix began to market commercially available 
DNA chips. Various microarray experimental platforms 
have been developed since then. Two major types of 
microarray platforms are used now. Spotted microarrays 
utilize oligonucleotides, cDNA, or small fragments of 
polymerase chain reaction products that correspond to 
mRNAs as the probes. The probes are synthesized on 
the array surface and then spotted onto glasses (Schena 
et al., 1995). Oligonucleotide microarrays, on the other 
hand, use short oligonucleotide probes designed to 
match parts of open reading frames. Oligonucleotide 
microarrays are produced by printing probes directly 
onto the array surfaces or by photolithographic synthesis 
of probes on silica substrates (Lipshutz et al., 1999). 
Oligonucleotide microarrays are the most widely used 
platforms in basic and applied researches (Joos and 
Kroeger, 2008). 
DNA microarray platform provides a high-throughput 
approach that enables researchers to monitor the 
expression of thousands of genes simultaneously. 
However, the intra- and inter-platform consistency of 
these platforms has been issued (Draghici et al., 2006). 
Standardizing global gene expression analysis between 
laboratories and across platforms can overcome these 
problems (Bammler et al., 2005). The standardized 
protocols include sample preparation, RNA isolation, 
amplified RNA (aRNA) synthesis, hybridization, and 
data analysis. The quality control check point for 
microarray experiment has also been established. For 
examples, the criteria for RNA sample include RNA 
concentration and purity. If the integrity number of 
RNA is more than eight, it means RNA is suitable 
for aRNA synthesis. The criteria for aRNA labeling 
include concentration and incorporation efficiency. If 
the incorporation efficiency is 30-60 dye molecules 
per 1,000 nucleotides, it means aRNA labeling is 
suitable for hybridization. The whole-gene expression 
profile according to the standardized protocol can yield 
data that are consistent between laboratories and are 
intrinsically comparable (Brazma et al., 2001; Knapen 
et al., 2009; Slonim and Yanai, 2009). In addition, 
comparison of the biological function instead of the list 
of differentially expressed genes can also overcome the 
inconsistency between different platforms (Li et al., 
2009).
DNA microarray technology applied in 
Chinese herbal medicine study
To overview the application of DNA microarray 
technology in Chinese herbal medicine study, we 
survey the number and objectives of papers dealing 
with frequently used Chinese medicinal herbs and their 
constituents, and further summarize how to utilize 
microarray in herbal research. The well-knowing or 
commonly used herbs and herbal compounds, such as 
Three Yellows Heart-Draining Decoction (三黃瀉心
湯 sān huáng xiè xīn tāng), Six-Ingredient Rehmannia 
Pill (六味地黃丸 liù wèi dì huáng wán), Ginkgo (銀杏 
yín xìng; the nuts of Ginkgo biloba), Ganoderma (靈芝 
líng zhī; Ganoderma lucidum) and Curcumae Longae 
Rhizoma (薑黃 jiāng huáng), are farther discussed in 
detail. 
To understand the number and the objectives of 
papers utilizing DNA microarray for herbal medicine 
study, we surveyed 297 frequently used Chinese 
medicinal herbs listed in Pharmacopoeia Commission 
of People’s Republic of China. We classified these 
medicinal herbs into 109 families and then applied 
PudMed search using "microarray" and individual 
herbal family as keywords. We found that microarray 
technology has been utilized in studying 62 herbal 
families and 2,674 articles applying microarray 
technology in the studies of these herbal families have 
been published in the years 1998 to 2011. The top 
ten herbal families applying microarray analysis are 
Cruciferae  (974 articles), Gramineae  (550 articles), 
Suidae  (325 articles),  Fabaceae  (206 articles), 
Solanaceae  (206 articles), Compositae  (43 articles), 
Vitaceae (42 articles), Rosaceae (38 articles), Malvaceae 
(36 articles), and Rutaceae (35 articles). Moreover, the 
number of papers is increasing year by year (Figure 1).
We further analyzed the objectives of articles 
applying microarray for the studies of herbal families. 
Most of the articles use plant microarray to investigate 
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the physiology, metabolism, or reproduction of 
herbs (O'Rourke et al., 2009). For examples, plant 
microarray has been utilized to elucidate the genes 
involved in flower development and to identify the key 
regulator of floral initiation (Kaufmann et al., 2010; 
Wellmer et al., 2006). It has also been employed to 
analyze the chloroplast processes of plants (Kleine and 
Leister, 2011). Moreover, because the genome-wide 
expression profiling is the output of the whole genomic 
regulatory patterns, it can provide a starting point for 
understanding the regulatory mechanisms of different 
developmental stages, cell types, and environmental 
conditions (Forment et al., 2005; Orlando et al., 2009). 
DNA microarray spotted with oligonucleotides matched 
to the nuclear 18S rRNA gene has been developed 
for authentication of ginseng (Zhu et al., 2008). 
After hybridization under optimal condition, specific 
fluorescent patterns can be detected for different Panax 
species. These findings suggested that DNA microarray 
designed to distinguish the polymorphisms of medicinal 
herbs can provide a reliable and objective method to 
authenticate the species, origins, culture conditions, and 
quality control of medicinal herbs (Wang et al., 2009; 
Zhang et al., 2007).
In addition to herbal physiology, microarray 
technology has been used to evaluate the host/herb 
interaction and to characterize the biological activities 
and mechanisms of herbal formulae and herbal 
compounds. For examples, Three Yellows Heart-
Draining Decoction (三黃瀉心湯  sān huáng xiè 
xīn tāng), also named as San-Huang-Xie-Xin-Tang 
(SHXXT), has been used for the treatment of liver 
diseases. Microarray analysis indicates that SHXXT 
and its components display a unique anti-proliferation 
activity via p53 and DNA damage signaling pathways in 
HepG2 cells (Cheng et al., 2008). PC-SPES is a dietary 
supplement that has been used as an alternative therapy 
in patients with prostate carcinoma (Kubota et al., 
2000; Small et al., 2000). The gene expression profile 
in cultured cells that have been exposed to PC-SPES 
shows that differential expression of genes involved 
in modulating cell cycle, cell structure, and androgen 
response may contribute to the PC-SPES-mediated 
cytotoxicity (Olaku and White, 2011). Six-Ingredient 
Rehmannia Pill (六味地黃丸 liù wèi dì huáng wán), as 
named as Yukmijihwang-tang (YMJ), has been widely 
used as an anti-aging herbal formula in Asian countries 
(Bonham et al., 2002). Microarray data indicate that 
YMJ enhances memory retention by inducing several 
genes that are involved in protecting neuronal cells, 
enhancing cell proliferation, and stimulating neurite 
growth (Hsieh et al., 2003). In addition, Danshen 
(the roots of Salvia miltiorrhiza )-Gegen (the roots 
of Pueraria lobata ) Decoction (黨參葛根湯 dǎng 
shēn gé gēn tāng) has been used for the treatment of 
cardiovascular diseases (Worldwide clinical trial listing, 
2008). Microarray data show that Danshen-Gegen 
decoction stimulates the proliferation of myocardium 
Figure 1. Number of publications of ten taxonomic families in the years 1998 to 2011. Bibliographic search using "microarray" and 
individual herbal taxonomic family as keywords was performed in January 2012.   
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cells via mitogen-activated protein kinase and insulin 
signaling pathways (Fong et al., 2011). These articles 
indicate that microarray can be applied to elucidate the 
therapeutic mechanisms of Chinese medicinal herbs 
with multiplex constitutes.
We further surveyed the articles applying microarray 
to study 297 frequently used Chinese medicinal herbs. 
Microarray technology has been employed in studying 
50 medicinal herbs and 405 articles have been published 
from 1998 to 2011 (Table 1). Most of the articles focus 
Table 1. List of Chinese medicinal herbs and herbal compounds that have been analyzed by microarray technology.
Familya Latin name (pinyin) b Compoundb
Acanthaceae (2) Baphicacanthus cusib (qīng dài ) (0) c Indigotin (2)
Anacardiaceae (6) Melaphis chinensis (wǔ bèi zǐ) (0) Gallic acid (6)
Araceae (3) Pinellia ternata (bàn xià) (3) Homogentisic acid (0)
Araliaceae (35) Panax ginseng (rén shēn) (16) Ginsenoside (12)
Panax notoginseng (sān qī) (2) Notoginsenoside (0)
Periploca sepium  (wǔ jiā pí) (0) Sesamin (5)
Arecaceae (48) Areca catechu (dà fù pí) (10) Catechin (38)
Aristolochiaceae (13) Aristolochia debilis (mǎ dōu líng) (3) Magnoflorin (0)
Aristolochia fangchi (guǎng fáng jǐ) (0) Aristolochic acid (10)
Aristolochia manshuriensis (guān mù tōng) (0) Aristolochic acid (10)
Berberidaceae (1) Epimedium brevicornum (yín yáng huò) (0) Icariin (1)
Bignoniaceae (14) Campsis grandiflora (líng xiāo huā) (0) Apigenin (10)
Oroxylum indicum (mù hú dié) (0) Baicalein (4)
Bombycidae (1) Bombyx batryticatus (bái jiāng cán) (0) 3-Hydroxy kynurenine (1)
Boraginaceae (3) Arnebia euchroma (zǐ cǎo) (0) Shikonin (3)
Bovidae (22) Calculus bovis (niú huáng) (0) Bilirubin (22)
Burseraceae (11) Commiphora myrrha (mò yào) (0) Eugenol (7)
Boswellia carteri (rǔ xiāng) (1) Boswellic acid (3)
Caryophyllaceae (44) Dianthus superbus (qú mài) (0) Anthocyanin (44)
Combretaceae (1) Quisqualis indica (shǐ jūn zǐ) (1) Quisqualic acid (0)
Compositae (9) Artemisia annua (qīng hāo) (3) Qinghaosu (3)
Artemisia argyi (ài yè) (0) Sesquiterpenoids (2)
Carthamus tinctorius (hóng huā) (1)
Cruciferae (4) Isatis indigotica (bǎn lán gēn) (0) Indigotin (2)
Rhaphanus sativus (lái fú zǐ) (0) Sinapine (1)
Sinapis alba (bái jiè zǐ) (1) Sinigrim (0)
Cucurbitaceae (13) Benincasa hispida  (dōng guā zǐ) (0) Citrulline (9)
Trichosanthes kirilowii (guā lóu gēn) (4) Campestol (0)
Cupressaceae (2) Platycladus orientalis (cè bǎi yè) (2) Thujene (0)
Cynomoriaceae (22) Cynomorium songaricum (suǒ yáng) (0) Saponin (22)
Caesalpiniaceae (1) Caesalpinia sappan (sū mù) (1) Barsilin (0)
Cannabidaceae (5) Cannabis sativa (huǒ má rén) (5) Trigonelline (0)
Ebenaceae (1) Diospyros kaki (shì dì) (1) Hydroxytriterpenic acid (0)
Equisetaceae (13) Equisetum hyemale (mù zéi) (0) Succinic acid (12)
Euphorbia kansui (gān suì) (1) Euphornin (0)
Eucommiaceae (1) Eucommia ulmoides (dù zhòng) (1)
Euphorbiaceae (29) Croton tiglium (bā dòu) (3)
Euphorbia helioscopia (zé qī) (0) Quercetin (26)
Fabaceae (94) Acacia catechu (ér chá) (1) Gambirdine (0)
Astragalus membranaceus (huáng qí) (3) Astragaloside (1)
Astragalus complanatus (huáng qí) (1) Complanatuside (0)
Cassia obtusifolia (cǎo jué míng) (0) Emodin (10)
Dolichos lablab (biǎn dòu) (0) Palmitic acid (15)
Gleditsia sinensis (zào jiá) (0) Curcumin (32)
Glycine max (dà dòu) (7)
Glycyrrhiza uralensis (gān cǎo) (0) Glycyrrhizin (4)
Pueraria lobata (gé gēn) (0) Daidzein (16)
Sophora flavescens (kǔ shēn gēn) (2) Matrine (1)
Sophora tonkinensis (guǎng dòu gēn) (0) Matrine (1)
Ginkgoaceae (8) Ginkgo biloba (shān dòu gēn) (8) Ginkgotoxin (0)
Gramineae (87) Coix lacryma (yì yǐ) (1)
Triticum aestivum (fú xiǎo mài) (86) Allantonin (0)
Haliotidae (1) Haliotis diversicolor (shí jué míng) (1) Conchiolin (0)
Hamamelidaceae (1) Liquidambar formosana (lù lù tōng) (0) 28-Noroleanoic acid (1)
Hirudinidae (2) Whitmanian pigra (shuǐ zhì) (0) Hirudin (2)
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Familya Latin name (pinyin) b Compoundb
Hyocraceae (20) Cordyceps sinensis (dōng chóng xià cǎo) (1) Cordycepic acid (19)
Labiatae (27) Scutellaria baicalensis (huáng qín) (5) Baiaclin (0)
Lycopus lucidus (zé lán) (0) Volatile oil (5)
Perilla frutescens (zǐ sū yè) (1)
Salvia miltiorrhiza (dān shēn) (10) Tanshinone (6)
Laminariaceae (38) Laminaria japonica (hǎi dài) (0) Alginate (38)
Lauraceae (5) Cinnamomum cassia (ròu guì) (1) Cinnamaldehyde (4)
Liliaceae (3) Anemarrhenae asphodeloides () (1) Timosaponin (0)
Simlax glabra  (tǔ fú líng) (2) Astilbin (0)
Loranthaceae (26) Taxillus chinensis (sāng jì shēng) (0) Quercetin (26)
Magnoliaceae (15) Magnolia biondii (xīn yí) (0) β-Pinene (1)
Magnolia officinalis (hòu pò) (14) Magnolol (0)
Myrtaceae (7) Eugenia caryophyllata (dīng xiāng) (0) Eugenol (7)
Orchidaceae (1) Anoectochilus formosanus () (1)
Piperacea (3) Piper nigrum (hú jiāo) (2) Piperine (1)
Polygalaceae (1) Polygala tenuifolia (yuǎn zhì) (1) Tenuigenin (0)
Polygonaceae (14) Rheum officinale (dà huáng) (4) Emodin (10)
Polyporaceae (9) Ganoderma lucidum (líng zhī) (8)
Polyporus umbellatus (zhū líng) (1) Polyporusterone (0)
Punicaceae (18) Punica granatum (shí liú pí) (0) Tannin (18)
Ranunculaceae (29) Paeonia suffruticosa  (mǔ dān pí) (0) Paeoniflorin (2)
Aconitum carmichaeli  (wū tóu) (0) Aconitine (1)
Anemone altaica  (jiǔ jié chāng pú) (0) Palmitic acid (15)
Coptis chinensis  (huáng lián) (1) Berberine (10)
Rosaceae (113) Agrimonia pilosa (xiān hè cǎo) (0) Leuteolin-7-glucoside (13)
Armeniaca vulgaris (kǔ xìng rén) (16) Amygdalin (1)
Chaenomeles speciosa  (mù guā) (0) Malic acid (5)
Eriobotrya japonica (pí pá yè) (0) Epicatechin (39)
Photinia serrulata  (shí nán) (0) Nerolidol (2)
Prunus armeniaca  (xìng rén) (16) Amygdalin (1)
Prunus humilis  (yù lǐ rén) (0) Amygdalin (1)
Prunus persica (táo rén) (16) Amygdalin (1)
Rubus chingii  (fù pén zǐ) (0) Ellagic acid (2)
Rubiaceae (15) Rubia cordifolia  (qiàn cǎo gēn) (0) Alizarin (15)
Rutaceae (78) Citrus aurantium  (zhǐ qiào (ké)) (57) Hesperidin (0)
Dictamnus dasycarpus  (bái xiān pí) (0) Psoralen (5)
Phellodendron amurense  (huáng bǎi) (0) Berberine (10)
Poncirus trifoliata (zhǐ shí) (2) Hesperidin (0)
Zanthoxylum bungeanum  (huā jiāo) (0) Cinnamaldehyde (4)
Sargassaceae (18) Sargassum pallidum  (hǎi zǎo) (0) Alginic acid (18)
Schizaeaceae (2) Lygodium japonicum (hǎi jīn shā) (0) Methylester (2)
Scrophlariaceae (24) Scrophullaria ningpoensis  (xuán shēn) (0) Harpagide (1)
Siphonlostegia chinensis (liú jì nú) (10) Coumarin (13)
Solanaceae (26) Lycium barbarum  (gǒu qǐ) (0) Betaine (26)
Sparganiaceae (5) Sparganium stoloniferum (jīng sān léng) (0) Benzeneethanol (5)
Suidae (51) Suis Vesica Fellea (zhū dǎn) (51)
Thymelaeaceae (1) Daphne genkwa (yuán huā) (0) Genkwanin (1)
Trogopterus (70) Trogopterus xanthipes  (wǔ líng zhī) (0) Catechol (70)
Typhaceae (7) Typha angustifolia (xiāng pú) (0) Naringenin (7)
Umbelliferae (4) Angelica dahurica (bái zhǐ) (0) Sitosterol (1)
Angelica sinensis (dāng guī) (0) Butylidenephthalide (1)
Ligusticum sinense (gǎo běn) (0) Limonene (1)
Notopterygium incisum (qiāng huó) (0) 1,8-Cineole (1)
Violaceae (15) Viola philippica (zǐ huā dì dīng) (0) Palmitic acid (15)
Zingiberaceae (34) Alpinia oxyphylla (yì zhì rén) (0) 1,8-Cineole (1)
Amomum cardamomum  (bái dòu kòu) (0) 1,8-Cineole (1)
Curcuma longa  (jiāng huáng) (12) Turmerone (0)
Curcuma wenyujin (yù jīn) (0) Curcumin (32)
Kaempferia galanga  (shān nài) (0) Kaempferol (9)
Alpinia officinarum (gāo liáng jiāng) (0) Curcumin (32)
Zygophyllaceae (9) Tribulus terrestris (jí lí) (0) Kaempferol (9)
a The number of publication enclosed in the parentheses is the sum of articles regarding herbs and compounds.
b The number of publications from 1998 to 2011 is enclosed in the parentheses.
c Because some publications analyze compounds but not plants, there is no publication for plants.
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on the elucidation of mechanisms of medicinal herbs, 
while others discover novel therapeutic potentials of 
herbs. For examples, ginkgo (銀杏 yín xìng; the nuts 
of Ginkgo biloba) leaf extract EGb 761 is widely used 
in patients with neurodisorders, and it is the top-selling 
herbal drug in the world (Mahadevan and Park, 2008). 
Gene expression profiling of brains of mice given with 
EGb761 shows that EGb761 affects neuroactive ligand-
receptor interaction pathway and up-regulates the 
subgroup of dopamine receptors, especially dopamine 
receptor 1a. Ginkgo biloba increases the expression of 
dopamine receptor 1 in brain, may explain why EGb761 
can be used to treat neurodisorders (Su et al., 2009). 
In addition to the well-known efficacy of EGb761 in 
neurodisorders, novel therapeutic potentials of EGb761 
can be predicted by microarray analysis. Bidon et al. 
(2009) found that EGb 761 induces a gain in muscular 
mass that is associated with an improvement of the 
muscular performances. DNA microarray shows that 
these modifications are contributed by genes related 
to myogenesis via transforming growth factor-β 
signaling pathway and to energy production via fatty 
acids and glucose oxidation. Their findings suggest 
that EGb 761 may be a novel treatment for sarcopenia. 
Ganoderma (靈芝 líng zhī; Ganoderma lucidum) is a 
well-known immunomodulatory herb (Xu et al., 2011). 
Immunization of polysaccharide from Ganoderma 
lucidum  (PS-G) increases IgG2a levels in mice, 
suggesting that PS-G effectively promotes the activation 
and maturation of immature dendritic cells, preferring 
a T helper 1 response. Microarray data of dendritic 
cells exposed to PS-G show that genes associated 
with phagocytosis are decreased and genes associated 
with proinflammatory chemokines and cytokines 
are increased. Their results also demonstrate that the 
microarray data are correlated with the in vivo effect 
of the immune-enhancing compound PS-G (Lin et al., 
2006). Pinelliae Rhizoma (半夏 bàn xià; the roots of 
Pinellia ternate ) extract (PRe) has been used to treat 
cough, asthma, and psychological diseases (Kang et 
al., 2005). Microarray analysis of mice exposed to 
psychological stress shows that the expression of genes 
that are altered in response to psychological stress is 
restored to normal levels in PRe-treated mice (Kim 
et al., 2010). Araliae Cordatae Rhizoma et Radix (當
歸 dāng guī; the roots of Angelica sinensis) has been 
widely used in skin and wound care (Majewska and 
Gendaszewska-Darmach, 2011). An aqueous isolate 
(SBD.4) of Angelica sinensis  increases the strength 
of healed wounds in older rats. Microarray analysis of 
SBD.4 in zebrafish angiogenesis model and human skin 
substitutes further reveals a bioactivity profile consistent 
with skin repair and regeneration (Zhao et al., 2011).
Figure 2. Chemical structures of representative herbal compounds.
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In addition to Chinese medicinal herbs, we also 
surveyed the number and objectives of articles applying 
microarray analysis to study herbal compounds. The 
structures of representative compounds are shown in 
Figure 2. A total of 1,196 articles has been published 
from 2000 to 2011, and the number of papers is 
increasing year by year (Figure 3). Most of the 
articles aim to elucidate the mechanisms of herbal 
compounds, while others predict the novel therapeutic 
potentials or toxicological effects of compounds. For 
examples, curcumin is a major chemical component 
of Curcumae Longae Rhizoma (薑黃 jiāng huáng; 
the roots of Curcuma longa) , which has been used as 
a spice to give a specific flavor and yellow color to 
curry (Govindarajan, 1980). Curcumin displays anti-
carcinogenic properties in animals (Huang et al., 1988). 
Microarray analysis indicates that curcumin exhibits a 
novel anti-metastatic effect via regulating the expression 
of certain genes involved in metastasis (Chen et al., 
2004). Aristolochic acid (AA), the major constitute of 
Aristolochia species, is a carcinogenic and nephrotoxic 
chemical (Lai et al., 2009). Microarray analysis 
shows that most AA-altered genes are connected with 
nuclear factor-κB (NF-κB), suggesting that NF-κB 
plays a critical role in the pathogenesis of AA-induced 
renal diseases (Chen et al., 2010). Emodin, the active 
principle of herbal medicine derived from genera 
Rheum and Polygonum, is a well-known inhibitor of 
casein kinase II (CK2) (Yim et al., 1999). Microarray 
analysis of mice testis exposed to emodin shows that 
emodin causes testicular toxicity via apoptosis through 
insulin-like growth factor-1 receptor signaling pathway 
and affects CK2, spermatogenesis, and sperm motility 
via four pathways, such as tumor necrosis factor 
receptor 1 signaling (Oshida et al., 2011). Silymarin, 
a flavonoligan mixture of milk thistle (Silybum 
marianum ), is a well-known hepatoprotective drug 
(Abenavoli et al., 2010). Microarray analysis of carbon 
tetrachloride-treated livers in mice shows that silymarin 
alters the transforming growth factor-β-mediated 
pathways and downregulates the expression levels of 
cytoskeleton organization genes and mitochondrion 
electron-transfer chain genes, such as cytochrome c 
oxidase Cox6a2, Cox7a1, and Cox8b genes (Li et al., 
2012). By investigating the herbal compounds that 
have employed microarray analysis, we found that 
most of the articles aim to elucidate the mechanisms of 
herbal compounds and to predict the novel therapeutic 
potential or toxicological effects of compounds (Cheng 
et al., 2007; Cheng et al., 2009; Leow et al., 2011). 
Therefore, construction of databases containing all the 
published gene expression profiles of herbs may provide 
the basis for the comparison between herbal compounds 
and drugs, and for the study of drug/gene interaction.
Figure 3. Number of publications of representative herbal compounds in the years 1998 to 2011. Bibliographic search using 
"microarray" and individual herbal compound as keywords was performed in January 2012. Data are the sum of articles within 
three years.
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Conclusion
Although thousands of papers applying DNA 
microarray for Chinese herbal study have been 
published since 1998, most of the articles focus on the 
elucidation of mechanisms of certain biological effects 
of herbs. DNA microarray is a high-throughput platform 
that enables researchers to monitor the expression of 
thousands of genes simultaneously. The linkage between 
gene expression signatures can be a powerful tool 
for the comparisons of drugs with or without defined 
mechanisms. Therefore, a large-scaled genome-wide 
expression profiling can provide a comprehensively and 
globally view for the mechanisms, biological activities, 
therapeutic potential, and toxicology of drugs (Chang 
et al., 2011; Chang et al., 2012; Fernandes et al., 2009; 
Gidrol et al., 2009; Lu et al., 2012; Ulrich-Merzenich 
et al., 2010). For examples, the large-scaled gene 
expression analysis of toxin-treated cells and animals 
has been utilized to recognize the toxic potentials of 
novel drug candidates (Ganter et al., 2005). The large-
scaled gene expression profile can be used to identify 
the disease target for drug development (Whitfield 
et al., 2006). Moreover, the therapeutic efficacy can 
be predicted in vitro  on the basis of gene expression 
signatures (Gunther et al., 2003). Extracts prepared from 
medicinal plants contain various molecules with potent 
biological activities. However, it is difficult to analyze 
the biological activities of these extracts because of their 
complex constituents. To overcome this issue, we link 
the formulae-altered genes with drugs- or compounds-
regulated genes by Connectivity Map (Cheng et al., 
2010). Connectivity Map compares lists of differential 
expressed genes to a library of experiments evaluating 
the effects of small molecules and genetic events on 
gene expression (Lamb et al., 2006; Lamb, 2007). 
Connectivity Map searches for connections among 
molecules sharing similar mechanisms of action. By 
connecting the gene expression signatures of formulae 
with those of drugs, we can anticipate the novel 
therapeutic potential of herbs and further identify the 
phytochemical candidate for drug development. In 
the future, construction of the bioactivity database 
containing large-scaled gene expression profiles of 
quality control herbs can be applied to analyze the 
biological events induced by herbs, to predict the 
therapeutic potential of herbs, to evaluate the safety of 
herbs, and to identify the drug candidate of herbs. In 
addition, such a database can be served as a translational 
platform between traditional Chinese herbal medicine 
and Western medicine.
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